These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 25318907)
1. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands. Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC Malar J; 2014 Oct; 13():406. PubMed ID: 25318907 [TBL] [Abstract][Full Text] [Related]
2. Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy. Gresty KJ; Gray KA; Bobogare A; Wini L; Taleo G; Hii J; Cheng Q; Waters NC Malar J; 2014 Oct; 13():402. PubMed ID: 25311473 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706 [TBL] [Abstract][Full Text] [Related]
4. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375 [TBL] [Abstract][Full Text] [Related]
6. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia. Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992 [TBL] [Abstract][Full Text] [Related]
10. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011. Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China. She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899 [TBL] [Abstract][Full Text] [Related]
12. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future. Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A Malar J; 2012 Apr; 11():113. PubMed ID: 22498364 [TBL] [Abstract][Full Text] [Related]
13. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165 [TBL] [Abstract][Full Text] [Related]
14. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu. Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD Malar J; 2010 Apr; 9():89. PubMed ID: 20370920 [TBL] [Abstract][Full Text] [Related]
15. Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen. Bamaga OA; Mahdy MA; Lim YA Acta Trop; 2015 Sep; 149():59-63. PubMed ID: 26001972 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Golassa L; Enweji N; Erko B; Aseffa A; Swedberg G Malar J; 2014 Mar; 13():120. PubMed ID: 24674605 [TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998 [TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms. Jovel IT; Ferreira PE; Veiga MI; Malmberg M; Mårtensson A; Kaneko A; Zakeri S; Murillo C; Nosten F; Björkman A; Ursing J Infect Genet Evol; 2014 Jun; 24():111-5. PubMed ID: 24657918 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia. Hassen J; Alemayehu GS; Dinka H; Golassa L Malar J; 2022 Oct; 21(1):286. PubMed ID: 36207750 [TBL] [Abstract][Full Text] [Related]
20. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea. Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM Malar J; 2015 Jan; 14():37. PubMed ID: 25626445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]